Immunohistochemical examination on the distribution of cells expressed lymphatic endothelial marker podoplanin and LYVE-1 in the mouse tongue tissue

Acta Histochemica et Cytochemica

Volumn 43, Issue 2, 2010, Pages 61-68

  Noda, Yuya ^a   Amano, Ikuko ^a   Hata, Minoru ^a   Kojima, Hiroshi ^a   Sawa, Yoshihiko ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Lymphatic vessels; Lyve 1; Macrophages; Podoplanin

Indexed keywords

EID: 77951722115     PISSN: 00445991     EISSN: 13475800     Source Type: Journal    
DOI: 10.1267/ahc.10008     Document Type: Article

References (40)

1. Banerji, S., Ni, J., Wang, S. X., Clasper, S., Su, J., Tammi, R., Jones, M. and Jackson, D. G. (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144; 789-801.
2. Breiteneder-Geleff, S., Soleiman, A., Kowalski, H., Horvat, R., Amann, G., Kriehuber, E., Diem, K., Weninger, W., Tschachler, E., Alitalo, K. and Kerjaschki, D. (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154; 385-394.
3. Cho, C. H., Koh, Y. J., Han, J., Sung, H. K., Jong, L. H., Morisada, T., Schwendener, R. A., Brekken, R. A., Kang, G., Oike, Y., Choi, T. S., Suda, T., Yoo, O. J. and Koh, G. Y. (2007) Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ. Res. 100; 47-57.
4. Dobbs, L. G., Williams, M. C. and Gonzalez, R. (1988) Mono-clonal antibodies specific to apical surfaces of rat alveolar type I cells bind to surfaces of cultured, but not freshly isolated, type II cells. Biochim. Biophys. Acta 970; 146-156.
5. Gale, N. W., Prevo, R., Espinosa, J., Ferguson, D. J., Dominguez, M. G., Yancopoulos, G. D., Thurston, G. and Jackson, D. G. (2007) Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. Mol. Cell Biol. 27; 595-604.
6. Gröger, M., Loewe, R., Holnthoner, W., Embacher, R., Pillinger, M., Herron, S. G., Wolff, K. and Petzelbauer, P. (2004) IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. J. Immunol. 173; 7161-7169.
7. Guo, D. C., Pannu, H., Tran-Fadulu, V., Papke, C. L., Yu, R. K., Avidan, N., Bourgeois, S., Estrera, A. L., Safi, H. J., Sparks, E., Amor, D. and Ades, L. et al. (2007) Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet. 39; 1488-1493.
8. Hantusch, B., Kalt, R., Krieger, S., Puri, C. and Kerjaschki, D. (2007) Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. BMC Mol. Biol. 8; 20.
9. Hata, M., Ueki, T., Sato, A., Kojima, H. and Sawa, Y. (2008) Expression of podoplanin in the mouse salivary glands. Arch. Oral Biol. 53; 835-841.
10. Hirakawa, S., Hong, Y. K., Harvey, N., Schacht, V., Matsuda, K., Libermann, T. and Detmar, M. (2003) Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am. J. Pathol. 162; 575-586.
11. Hong, Y. K., Harvey, N., Noh, Y. H., Schacht, V., Hirakawa, S., Detmar, M. and Oliver, G. (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225; 351-357.
12. Huang, S. S., Liu, I. H., Smith, T., Shah, M. R., Johnson, F. E. and Huang, J. S. (2006) CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels. FEBS Lett. 580; 6259-6268.
13. Iwasawa, K., Kameyama, T., Ishikawa, H. and Sawa, Y. (2008) Induction of ICAM-1 and VCAM-1 on the mouse lingual lymphatic endothelium with TNF-α. Acta Histochem. Cytochem. 41; 115-120.
14. Jackson, D. G. (2009) Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol. Rev. 230; 216-231.
15. Jokinen, C. H., Dadras, S. S., Goldblum, J. R., van de Rijn, M., West, R. B. and Rubin, B. P. (2008) Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms. Am. J. Clin. Pathol. 129; 886-893.
16. Kato, Y., Kaneko, M. K., Kunita, A., Ito, H., Kameyama, A., Ogasawara, S., Matsuura, N., Hasegawa, Y., Suzuki-Inoue, K., Inoue, O., Ozaki, Y. and Narimatsu, H. (2008) Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci. 99; 54-61.
17. Kawaguchi, H., El-Naggar, A. K., Papadimitrakopoulou, V., Ren, H., Fan, Y. H., Feng, L., Lee, J. J., Kim, E., Hong, W. K., Lippman, S. M. and Mao, L. (2008) Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J. Clin. Oncol. 26; 354-360.
18. Kriehuber, E., Breiteneder-Geleff, S., Groeger, M., Soleiman, A., Schoppmann, S. F., Stingl, G., Kerjaschki, D. and Maurer, D. (2001) Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194; 797-808.
19. Kuroshima, S., Sawa, Y., Kawamoto, T., Yamaoka, Y., Notani, K., Yoshida, S. and Inoue, N. (2004) Expression of Toll-like receptors 2 and 4 on human intestinal lymphatic vessels. Microvasc. Res. 67; 90-95.
20. Marsee, D. K., Pinkus, G. S. and Hornick, J. L. (2009) Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells. Appl. Immunohistochem. Mol. Morphol. 17; 102-107.
21. Martín-Villar, E., Scholl, F. G., Gamallo, C., Yurrita, M. M., Muñoz-Guerra, M., Cruces, J. and Quintanilla, M. (2005) Characterization of human PA2.26 antigen (T1α-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int. J. Cancer 113; 899-910.
22. Ordóñez, N. G. (2005) D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum. Pathol. 36; 372-380.
23. Ordóñez, N. G. (2006) Podoplanin: a novel diagnostic immuno-histochemical marker. Adv. Anat. Pathol. 13; 83-88.
24. Otsuki, Y., Kubo, H. and Magari, S. (1990) Immunohisto-chemical differentiation between lymphatic vessels and blood vessels-use of anti-basement membrane antibodies and anti-factor VIII-related antigen. Arch. Histol. Cytol. 53 Suppl; 95-105.
25. Petrova, T. V., Makinen, T., Makela, T. P., Saarela, J., Virtanen, I., Ferrell, R. E., Finegold, D. N., Kerjaschki, D., Ylä-Herttuala, S. and Alitalo, K. (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21; 4593-4599.
26. Raica, M., Cimpean, A. M. and Ribatti, D. (2008) The role of podoplanin in tumor progression and metastasis. Anticancer Res. 28; 2997-3006.
27. Ramirez, M. I., Millien, G., Hinds, A., Cao, Y. X., Seldin, D. C. and Williams, M. C. (2003) T1a, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolous formation at birth. Dev. Biol. 256; 61-72.
28. Rishi, A. K., Joyce-Brady, M., Fisher, J., Dobbs, L. G., Floros, J., VanderSpek, J., Brody, J. S. and Williams, M. C. (1995) Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives. Dev. Biol. 167; 294-306.
29. Sawa, Y., Iwasawa, K. and Ishikawa, H. (2008) Expression of podoplanin in the mouse tooth germ and apical bud cells. Acta Histochem. Cytochem. 41; 121-126.
30. Schacht, V., Ramirez, M. I., Hong, Y. K., Hirakawa, S., Feng, D., Harvey, N., Williams, M., Dvorak, A. M., Dvorak, H. F., Oliver, G. and Detmar, M. (2003) T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22; 3546-3556.
31. Schacht, V., Dadras, S. S., Johnson, L. A., Jackson, D. G., Hong, Y. K. and Detmar, M. (2005) Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am. J. Pathol. 166; 913-921.
32. + macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J. Pathol. 209; 67-77.
33. Suzuki-Inoue, K., Kato, Y., Inoue, O., Kaneko, M. K., Mishima, K., Yatomi, Y., Yamazaki, Y., Narimatsu, H. and Ozaki, Y. (2007) Involvement of the snake toxin receptor CLEC-2, in podoplaninmediated platelet activation, by cancer cells. J. Biol. Chem. 282; 25993-26001.
34. Vandekerckhove, J. and Weber, K. (1979) The complete amino acid sequence of actins from bovine aorta, bovine heart, bovine fast skeletal muscle, and rabbit slow skeletal muscle. A protein-chemical analysis of muscle actin differentiation. Differentiation 14; 123-133.
35. Wetterwald, A., Hoffstetter, W., Cecchini, M. G., Lanske, B., Wagner, C., Fleisch, H. and Atkinson, M. (1996) Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone 18; 125-132.
36. Wicki, A. and Christofori, G. (2007) The potential role of podoplanin in tumour invasion. Br. J. Cancer 96; 1-5.
37. Wigle, J. T. and Oliver, G. (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98; 769-778.
38. Williams, M. C., Cao, Y., Hinds, A., Rishi, A. K. and Wetterwald, A. (1996) T1α protein is developmentally regulated and expressed by alveolar type I cells, choroid plexus and ciliary epithelia of adult rats. Am. J. Respir. Cell Mol. Biol. 14; 577-585.
39. Yu, H., Gibson, J. A., Pinkus, G. S. and Hornick, J. L. (2007) Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors. Am. J. Clin. Pathol. 128; 776-782.
40. Yuan, P., Temam, S., El-Naggar, A., Zhou, X., Liu, D. D., Lee, J. J. and Mao, L. (2006) Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 107; 563-569.